Home688319 • SHA
add
Chengdu Olymvax Biopharmaceuticals Inc
Previous close
¥24.60
Day range
¥24.30 - ¥27.55
Year range
¥10.07 - ¥34.68
Market cap
10.09B CNY
Avg Volume
6.04M
P/E ratio
171.26
Dividend yield
-
Primary exchange
SHA
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 201.07M | 25.38% |
Operating expense | 139.35M | 20.02% |
Net income | 34.28M | 7.22% |
Net profit margin | 17.05 | -14.49% |
Earnings per share | — | — |
EBITDA | 54.11M | 44.28% |
Effective tax rate | 17.41% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 217.27M | -19.37% |
Total assets | 1.94B | 13.90% |
Total liabilities | 976.63M | 24.15% |
Total equity | 968.34M | — |
Shares outstanding | 405.93M | — |
Price to book | 10.42 | — |
Return on assets | 6.23% | — |
Return on capital | 8.74% | — |
Cash Flow
Net change in cash
| (CNY) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 34.28M | 7.22% |
Cash from operations | 52.78M | 1,454.28% |
Cash from investing | -58.29M | -5.27% |
Cash from financing | -9.14M | -157.22% |
Net change in cash | -14.65M | 66.15% |
Free cash flow | -5.15M | 93.94% |
About
Founded
Dec 11, 2009
Website
Employees
463
